ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,704Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 278

$668K Total Retail Price of All Prescriptions

Rank: 60 out of 278

352 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 8,824 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
OMEPRAZOLE 520 476 1 3
PRAVASTATIN SODIUM 373 348 2 16
WARFARIN SODIUM 318 294 3 11
AMLODIPINE BESYLATE 316 294 4 7
LISINOPRIL 287 264 5 5
LEVOTHYROXINE SODIUM 259 235 6 2
METOPROLOL TARTRATE 241 236 7 9
METOPROLOL SUCCINATE 231 213 8 10
HYDROCODONE-ACETAMINOPHEN 207 148 S3 9 1
FUROSEMIDE 192 158 10 6
TRAMADOL HCL 171 164 11 22
HYDROCHLOROTHIAZIDE 141 141 12 15
ATENOLOL 135 134 13 18
GLIMEPIRIDE 127 113 14 28
METFORMIN HCL ER 122 100 15 76
SERTRALINE HCL 118 112 16 25
PAROXETINE HCL 109 90 17 57
CRESTOR 104 99 18 19
FENOFIBRATE 99 95 19 64
GABAPENTIN 98 83 20 12
CLONIDINE HCL 98 95 20 50
SIMVASTATIN 96 91 22 4
POTASSIUM CHLORIDE 89 85 23 17
KLOR-CON M20 88 71 24 42
LOSARTAN POTASSIUM 86 77 25 24
DONEPEZIL HCL 85 85 26 29
CARVEDILOL 85 83 26 23
AZITHROMYCIN 81 72 28 39
ATORVASTATIN CALCIUM 80 73 29 13
NAMENDA 79 79 30 48
ALLOPURINOL 79 73 30 38
FLUTICASONE PROPIONATE 78 63 32 44
DIGOXIN 72 72 33 40
GLIPIZIDE XL 71 57 34 160
AGGRENOX 67 67 35 274
PROAIR HFA 65 54 36 34
CLOPIDOGREL 65 59 36 20
HUMALOG 64 61 38 173
ENALAPRIL MALEATE 64 61 38 70
SPIRIVA 63 56 40 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 58 41 98
PANTOPRAZOLE SODIUM 62 59 41 36
ACETAMINOPHEN-CODEINE 62 50 S3 41 144
CYMBALTA 61 44 44 41
CITALOPRAM HBR 61 55 44 21
ISOSORBIDE MONONITRATE ER 60 47 46 33
METHYLPREDNISOLONE 60 53 46 124
CEPHALEXIN 58 54 48 92
ADVAIR DISKUS 58 54 48 45
RANITIDINE HCL 56 49 50 27
DIOVAN 53 50 51 43
ALENDRONATE SODIUM 53 47 51 51
FORTICAL 52 52 53 348
NEXIUM 52 48 53 14
LEVOFLOXACIN 51 46 55 66
FLUOXETINE HCL 50 49 56 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.